Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, tolerability, and pharmacokinetics of CTP-499 in diabetic nephropathy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• CTP-499 (CTP-499)

Snippet

Sponsor: Concert Pharmaceuticals | Conditions: Diabetic Nephropathy | Phase 1 | Status: COMPLETED